ArticleJournal of translational medicine2013

Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer.

Emily K Mader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.